Amylyx Pharmaceuticals Announces FDA Advisory Committee Supports Approval of AMX0035 for the Treatment of ALS

FDA Advisory Committee voted 7:2 that the available evidence of effectiveness is sufficient to support approval of AMX0035 for the treatment of ALS If approved, AMX0035 will be the first treatment in ALS that has demonstrated a significant...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news